The PPARs: From Orphan Receptors to Drug Discovery
The DOI matches its Crossref record; 215 of the 216 references it cites were found in a registry or an index.
Abstract
ADVERTISEMENT RETURN TO ISSUEPerspectiveNEXTThe PPARs: From Orphan Receptors to Drug Discovery†Timothy M. Willson, Peter J. Brown, Daniel D. Sternbach, and Brad R. HenkeView Author Information Department of Medicinal Chemistry, Glaxo Wellcome Research & Development, Research Triangle Park, North Carolina 27709 Cite this: J. Med. Chem. 2000, 43, 4, 527–550Publication Date (Web):February 24, 2000Publication History Received8 November 1999Published online24 February 2000Published inissue 1 February 2000https://pubs.acs.org/doi/10.1021/jm990554ghttps://doi.org/10.1021/jm990554greview-articleACS PublicationsCopyright © 2000 American Chemical SocietyRequest reuse permissionsArticle Views6740Altmetric-Citations1452LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-Alertsclose SUBJECTS:Agonists,Ligands,Lipids,Receptors,Rodent models Get e-Alerts
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Pemafibrate is an extremely selective PPARα agonist (subtype selectivity > 5000-fold for PPARγ and > 11,000-fold for PPARδ, respectively) [49, 50].”
From Pemafibrate, a new selective PPARα modulator: drug concept and its clinical applications for dyslipidemia and metabolic diseases (2020) · cites this paper as [50]
In the citing paper
“The PPARα activation by pemafibrate was > 2500 times stronger than fenofibric acid, the active form of fenofibrate.”
From Pemafibrate, a new selective PPARα modulator: drug concept and its clinical applications for dyslipidemia and metabolic diseases (2020) · cites this paper as [50]
Citations
Cites
Exploring the Metabolic and Genetic Control of Gene Expression on a Genomic Scale
DeRisi, J. L., Iyer, V. R., & Brown, P. O. (1997) · Science · doi:10.1126/science.278.5338.680 · Cited by 4,456
Self-citationA Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,529
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Self-citationActivation of a member of the steroid hormone receptor superfamily by peroxisome proliferators
Issemann, I., & Green, S. (1990) · Nature · doi:10.1038/347645a0 · Cited by 3,519
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
Jiang, C., Ting, A. T., & Seed, B. (1998) · Nature · doi:10.1038/34184 · Cited by 2,899
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Braissant, O., Foufelle, F., Scotto, C., Dauça, M., & Wahli, W. (1996) · Endocrinology · doi:10.1210/endo.137.1.8536636 · Cited by 2,217
mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I., & Spiegelman, B. M. (1994) · Genes & Development · doi:10.1101/gad.8.10.1224 · Cited by 2,181
Kliewer, S. A., Sundseth, S. S., Jones, S. A., Brown, P. J., Wisely, G. B., Koble, C. S., Devchand, P., Wahli, W., Willson, T. M., Lenhard, J. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.9.4318 · Cited by 2,164
Self-citationPPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro
Rosen, E. D., Sarraf, P., Troy, A. E., Bradwin, G., Moore, K., Milstone, D. S., Spiegelman, B. M., & Mortensen, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80211-7 · Cited by 2,079
Kliewer, S. A., Lenhard, J. M., Willson, T. M., Patel, I., Morris, D. C., & Lehmann, J. M. (1995) · Cell · doi:10.1016/0092-8674(95)90194-9 · Cited by 2,028
Self-citationLigand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
Nolte, R. T., Wisely, G. B., Westin, S., Cobb, J. E., Lambert, M. H., Kurokawa, R., Rosenfeld, M. G., Willson, T. M., Glass, C. K., & Milburn, M. V. (1998) · Nature · doi:10.1038/25931 · Cited by 1,958
Self-citationPPARγ Is Required for Placental, Cardiac, and Adipose Tissue Development
Barak, Y., Nelson, M. C., Ong, E. S., Jones, Y. Z., Ruiz-Lozano, P., Chien, K. R., Koder, A., & Evans, R. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80209-9 · Cited by 1,956
Oxidized LDL Regulates Macrophage Gene Expression through Ligand Activation of PPARγ
Nagy, L., Tontonoz, P., Alvarez, J. G. A., Chen, H., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81574-3 · Cited by 1,860
PPARγ Promotes Monocyte/Macrophage Differentiation and Uptake of Oxidized LDL
Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A., & Evans, R. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81575-5 · Cited by 1,797
Mechanism of Action of Fibrates on Lipid and Lipoprotein Metabolism
Staels, B., Dallongeville, J., Auwerx, J., Schoonjans, K., Leitersdorf, E., & Fruchart, J.-C. (1998) · Circulation · doi:10.1161/01.cir.98.19.2088 · Cited by 1,786
Kliewer, S. A., Umesono, K., Noonan, D. J., Heyman, R. A., & Evans, R. M. (1992) · Nature · doi:10.1038/358771a0 · Cited by 1,741
PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
Spiegelman, B. M. (1998) · Diabetes · doi:10.2337/diabetes.47.4.507 · Cited by 1,730
Low Density Lipoprotein Oxidation and Its Pathobiological Significance
Steinberg, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.34.20963 · Cited by 1,642
Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia
Fleury, C., Neverova, M., Collins, S., Raimbault, S., Champigny, O., Levi-Meyrueis, C., Bouillaud, F., Seldin, M. F., Surwit, R. S., Ricquier, D., et al. (1997) · Nature Genetics · doi:10.1038/ng0397-269 · Cited by 1,631
Lehmann, J. M., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., & Kliewer, S. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3703 · Cited by 1,576
Self-citationAn Orphan Nuclear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway
Kliewer, S. A., Moore, J. T., Wade, L., Staudinger, J. L., Watson, M. A., Jones, S. A., McKee, D. D., Oliver, B. B., Willson, T. M., Zetterström, R. H., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)80900-9 · Cited by 1,539
Self-citationKliewer, S. A., Forman, B. M., Blumberg, B., Ong, E. S., Borgmeyer, U., Mangelsdorf, D. J., Umesono, K., & Evans, R. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.15.7355 · Cited by 1,400
Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors
Dreyer, C., Krey, G., Keller, H., Givel, F., Helftenbein, G., & Wahli, W. (1992) · Cell · doi:10.1016/0092-8674(92)90031-7 · Cited by 1,376
The PPARα–leukotriene B4 pathway to inflammation control
Devchand, P. R., Keller, H., Peters, J. M., Vazquez, M., Gonzalez, F. J., & Wahli, W. (1996) · Nature · doi:10.1038/384039a0 · Cited by 1,345
PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance
Kubota, N., Terauchi, Y., Miki, H., Tamemoto, H., Yamauchi, T., Komeda, K., Satoh, S., Nakano, R., Ishii, C., Sugiyama, T., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80210-5 · Cited by 1,342
Adipogenesis and Obesity: Rounding Out the Big Picture
Spiegelman, B. M., & Flier, J. S. (1996) · Cell · doi:10.1016/s0092-8674(00)81359-8 · Cited by 1,269
Krey, G. D., Braissant, O., L’Horset, F., Kalkhoven, E., Perroud, M., Parker, M. G., & Wahli, W. (1997) · Molecular Endocrinology · doi:10.1210/me.11.6.779 · Cited by 1,221
The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene
Fajas, L., Auboeuf, D., Raspé, E., Schoonjans, K., Lefebvre, A.-M., Saladin, R., Najib, J., Laville, M., Fruchart, J.-C., Deeb, S., et al. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.30.18779 · Cited by 1,188
Schoonjans, K., Peinado‐Onsurbe, J., Lefebvre, A. M., Heyman, R. A., Briggs, M., Deeb, S., Staels, B., & Auwerx, J. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00918.x · Cited by 1,173
Activation of human aortic smooth-muscle cells is inhibited by PPARα but not by PPARγ activators
Staels, B., Koenig, W., Habib, A., Merval, R., Lebret, M., Torra, I. P., Delerive, P., Fadel, A., Chinetti, G., Fruchart, J.-C., et al. (1998) · Nature · doi:10.1038/31701 · Cited by 1,134
Cryptochromes: Blue Light Receptors for Plants and Animals
Cashmore, A. R., Jarillo, J. A., Wu, Y.-J., & Liu, D. (1999) · Science · doi:10.1126/science.284.5415.760 · Cited by 1,022
Okuno, A., Tamemoto, H., Tobe, K., Ueki, K., Mori, Y., Iwamoto, K., Umesono, K., Akanuma, Y., Fujiwara, T., Horikoshi, H., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1235 · Cited by 995
Differentiation and reversal of malignant changes in colon cancer through PPARγ
Sarraf, P., Mueller, E., Jones, D., King, F. J., DeAngelo, D. J., Partridge, J. B., Holden, S. A., Chen, L. B., Singer, S., Fletcher, C., et al. (1998) · Nature Medicine · doi:10.1038/2030 · Cited by 988
Chinetti, G., Griglio, S., Antonucci, M., Torra, I. P., Delerive, P., Majd, Z., Fruchart, J.-C., Chapman, J., Najib, J., & Staels, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25573 · Cited by 903
Chawla, A., Schwarz, E. J., Dimaculangan, D. D., & Lazar, M. A. (1994) · Endocrinology · doi:10.1210/en.135.2.798 · Cited by 873
Identification of a human nuclear receptor defines a new signaling pathway for CYP 3 A induction
Bertilsson, G., Heidrich, J., Svensson, K., Åsman, M., Jendeberg, L., Sydow-Bäckman, M., Ohlsson, R., Postlind, H., Blomquist, P., & Berkenstam, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.21.12208 · Cited by 872
Göttlicher, M., Widmark, E., Li, Q., & Gustafsson, J. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.10.4653 · Cited by 857
Interleukin-4-dependent production of PPAR-γ ligands in macrophages by 12/15-lipoxygenase
Huang, J. T., Welch, J. S., Ricote, M., Binder, C. J., Willson, T. M., Kelly, C., Witztum, J. L., Funk, C. D., Conrad, D., & Glass, C. K. (1999) · Nature · doi:10.1038/22572 · Cited by 855
Self-citationTerminal Differentiation of Human Breast Cancer through PPARγ
Mueller, E., Sarraf, P., Tontonoz, P., Evans, R. M., Martin, K. J., Zhang, M., Fletcher, C., Singer, S., & Spiegelman, B. M. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80047-7 · Cited by 851
Bais, C., Santomasso, B., Coso, O., Arvanitakis, L., Raaka, E. G., Gutkind, J. S., Asch, A. S., Cesarman, E., Gerhengorn, M. C., & Mesri, E. A. (1998) · Nature · doi:10.1038/34193 · Cited by 829
Biologically erodable microspheres as potential oral drug delivery systems
Mathiowitz, E., Jacob, J. S., Jong, Y. S., Carino, G. P., Chickering, D. E., Chaturvedi, P., Santos, C. A., Vijayaraghavan, K., Montgomery, S., Bassett, M., et al. (1997) · Nature · doi:10.1038/386410a0 · Cited by 823
Elstner, E., Müller, C., Koshizuka, K., Williamson, E. A., Park, D., Asou, H., Shintaku, P., Said, J. W., Heber, D., & Koeffler, H. P. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8806 · Cited by 805
Aitman, T. J., Glazier, A. M., Wallace, C. A., Cooper, L. D., Norsworthy, P. J., Wahid, F. N., Al-Majali, K. M., Trembling, P. M., Mann, C. J., Shoulders, C. C., et al. (1999) · Nature Genetics · doi:10.1038/5013 · Cited by 735
Ricote, M., Huang, J., Fajas, L., Li, A., Welch, J., Najib, J., Witztum, J. L., Auwerx, J., Palinski, W., & Glass, C. K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7614 · Cited by 721
Auboeuf, D., Rieusset, J., Fajas, L., Vallier, P., Frering, V., Riou, J. P., Staels, B., Auwerx, J., Laville, M., & Vidal, H. (1997) · Diabetes · doi:10.2337/diab.46.8.1319 · Cited by 697
The Pregnane X Receptor: A Promiscuous Xenobiotic Receptor That Has Diverged during Evolution
Jones, S. A., Moore, L. B., Shenk, J. L., Wisely, G. B., Hamilton, G. A., McKee, D. D., Tomkinson, N. C. O., LeCluyse, E. L., Lambert, M. H., Willson, T. M., et al. (2000) · Molecular Endocrinology · doi:10.1210/me.14.1.27 · Cited by 672
Self-citationTontonoz, P., Singer, S., Forman, B. M., Sarraf, P., Fletcher, J. A., Fletcher, C. D. M., Brun, R. P., Mueller, E., Altiok, S., Oppenheim, H., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.237 · Cited by 653
Hypertriglyceridemia, insulin resistance, and the metabolic syndrome
Grundy, S. M. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(99)00211-8 · Cited by 610
Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists
Mukherjee, R., Davies, P. J. A., Crombie, D. L., Bischoff, E. D., Cesario, R. M., Jow, L., Hamann, L. G., Boehm, M. F., Mondon, C. E., Nadzan, A. M., et al. (1997) · Nature · doi:10.1038/386407a0 · Cited by 605
Marx, N., Sukhova, G. K., Collins, T., Libby, P., & Plutzky, J. (1999) · Circulation · doi:10.1161/01.cir.99.24.3125 · Cited by 599
Update: Clinically Significant Cytochrome P‐450 Drug Interactions
Michalets, E. L. (1998) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1998.tb03830.x · Cited by 597
Activators of the nuclear receptor PPARγ enhance colon polyp formation
Saez, E., Tontonoz, P., Nelson, M. C., Alvarez, J. G. A., U, T. M., Baird, S. M., Thomazy, V. A., & Evans, R. M. (1998) · Nature Medicine · doi:10.1038/2042 · Cited by 587
PPARγ2 Regulates Adipose Expression of the Phosphoenolpyruvate Carboxykinase Gene
Tontonoz, P., Hu, E., Devine, J., Beale, E. G., & Spiegelman, B. M. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.1.351 · Cited by 559
Poynter, M. E., & Daynes, R. A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32833 · Cited by 550
Obesity Associated with a Mutation in a Genetic Regulator of Adipocyte Differentiation
Ristow, M., Müller-Wieland, D., Pfeiffer, A., Krone, W., & Kahn, C. R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810013391403 · Cited by 545
Modulation of AMPA receptor unitary conductance by synaptic activity
Benke, T. A., Lüthi, A., Isaac, J. T. R., & Collingridge, G. L. (1998) · Nature · doi:10.1038/31709 · Cited by 533
Macrophages in Human Atheroma Contain PPARγ
Marx, N., Sukhova, G., Murphy, C., Libby, P., & Plutzky, J. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65540-x · Cited by 529
Sher, T., Yi, H. F., McBride, O. W., & Gonzalez, F. J. (1993) · Biochemistry · doi:10.1021/bi00072a015 · Cited by 519
Loss-of-Function Mutations in PPARγ Associated with Human Colon Cancer
Sarraf, P., Mueller, E., Smith, W. M., Wright, H. M., Kum, J. B., Aaltonen, L. A., de la Chapelle, A., Spiegelman, B. M., & Eng, C. (1999) · Molecular Cell · doi:10.1016/s1097-2765(01)80012-5 · Cited by 506
Orphan Nuclear Receptors: Shifting Endocrinology into Reverse
Kliewer, S. A., Lehmann, J. M., & Willson, T. M. (1999) · Science · doi:10.1126/science.284.5415.757 · Cited by 499
Self-citationDemetri, G. D., Fletcher, C. D. M., Mueller, E., Sarraf, P., Naujoks, R., Campbell, N., Spiegelman, B. M., & Singer, S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3951 · Cited by 495
Hepatic Dysfunction Associated with Troglitazone
Watkins, P. B., & Whitcomb, R. W. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381314 · Cited by 446
Increasing the Complexity of Coactivation in Nuclear Receptor Signaling
Freedman, L. P. (1999) · Cell · doi:10.1016/s0092-8674(00)80708-4 · Cited by 434
Mukherjee, R., Jow, L., Croston, G. E., & Paterniti, J. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.12.8071 · Cited by 420
Staels, B., Vu-Dac, N., Kosykh, V. A., Saladin, R., Fruchart, J. C., Dallongeville, J., & Auwerx, J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117717 · Cited by 410
Berger, J., Leibowitz, M. D., Doebber, T. W., Elbrecht, A., Zhang, B., Zhou, G., Biswas, C., Cullinan, C. A., Hayes, N. S., Li, Y., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6718 · Cited by 410
Costet, P., Legendre, C., Moré, J., Edgar, A., Galtier, P., & Pineau, T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.45.29577 · Cited by 402
Schoonjans, K., Watanabe, M., Suzuki, H., Mahfoudi, A., Krey, G., Wahli, W., Grimaldi, P., Staels, B., Yamamoto, T., & Auwerx, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.33.19269 · Cited by 395
Regulation of cell movement is mediated by stretch-activated calcium channels
Lee, J., Ishihara, A., Oxford, G., Johnson, B., & Jacobson, K. (1999) · Nature · doi:10.1038/22578 · Cited by 391
Hofmann, C. (1994) · Endocrinology · doi:10.1210/en.134.1.264 · Cited by 387
Elbrecht, A., Chen, Y., Cullinan, C. A., Hayes, N., Leibowitz, M. D., Moller, D. E., & Berger, J. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1044 · Cited by 384
An Essential Regulator of Adipogenesis and Modulator of Fat Cell Function: PPARγ
Lowell, B. B. (1999) · Cell · doi:10.1016/s0092-8674(00)81654-2 · Cited by 383
Altiok, S., Xu, M., & Spiegelman, B. M. (1997) · Genes & Development · doi:10.1101/gad.11.15.1987 · Cited by 378
Cardiac and Glycemic Benefits of Troglitazone Treatment in NIDDM
Ghazzi, M. N., Perez, J. E., Antonucci, T. K., Driscoll, J. H., Huang, S. M., Faja, B. W., The Troglitazone Study Group, & Whitcomb, R. W. (1997) · Diabetes · doi:10.2337/diab.46.3.433 · Cited by 366
De Vos, P., Lefebvre, A. M., Miller, S. G., Guerre-Millo, M., Wong, K., Saladin, R., Hamann, L. G., Staels, B., Briggs, M. R., & Auwerx, J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118860 · Cited by 357
Interdomain communication regulating ligand binding by PPAR-γ
Shao, D., Rangwala, S. M., Bailey, S. T., Krakow, S. L., Reginato, M. J., & Lazar, M. A. (1998) · Nature · doi:10.1038/24634 · Cited by 349
Mode of Action of Peroxisome Proliferators as Hypolipidemic Drugs.
Hertz, R., Bishara-Shieban, J., & Bar-Tana, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.13470 · Cited by 339
Antidiabetic thiazolidinediones inhibit leptin (ob) gene expression in 3T3-L1 adipocytes.
Kallen, C. B., & Lazar, M. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5793 · Cited by 337
PPARγ3 mRNA: a distinct PPARγ mRNA subtype transcribed from an independent promoter
Fajas, L., Fruchart, J.-C., & Auwerx, J. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01273-3 · Cited by 336
Troglitazone action is independent of adipose tissue.
Burant, C. F., Sreenan, S., Hirano, K., Tai, T. A., Lohmiller, J., Lukens, J., Davidson, N. O., Ross, S., & Graves, R. A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119839 · Cited by 334
Lemberger, T., Saladin, R., Vázquez, M., Assimacopoulos, F., Staels, B., Desvergne, B., Wahli, W., & Auwerx, J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.3.1764 · Cited by 329
Growth Factors and Mitogen-Activated Protein Kinases
Force, T., & Bonventre, J. V. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.152 · Cited by 327
Nuclear-Receptor Ligands and Ligand-Binding Domains
Weatherman, R. V., Fletterick, R. J., & Scanlan, T. S. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.559 · Cited by 322
A peroxisome proliferator-activated receptor γ ligand inhibits adipocyte differentiation
Oberfield, J. L., Collins, J. L., Holmes, C. P., Goreham, D. M., Cooper, J. P., Cobb, J. E., Lenhard, J. M., Hull-Ryde, E. A., Mohr, C. P., Blanchard, S. G., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6102 · Cited by 316
Self-citationCentral hypothyroidism associated with retinoid X receptor-selective ligands
Sherman, S. I., Gopal, J., Haugen, B. R., Chiu, A. C., Whaley, K., Nowlakha, P., & Duvic, M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199904083401404 · Cited by 315
Thiazolidinediones block tumor necrosis factor-alpha-induced inhibition of insulin signaling.
Peraldi, P., Xu, M., & Spiegelman, B. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119715 · Cited by 314
BROCKMAN, J., GUPTA, R., & DUBOIS, R. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70072-1 · Cited by 313
Ashby, J., Brady, A., Elcombe, C. R., Elliott, B. M., Ishmael, J., Odum, J., Tugwood, J. D., Kettle, S., & Purchase, I. F. H. (1994) · Human & Experimental Toxicology · doi:10.1177/096032719401300201 · Cited by 313
Pioglitazone Induces In Vivo Adipocyte Differentiation in the Obese Zucker fa/fa Rat
Haliakon, S., Doaré, L., Foufelle, F., Kergoat, M., Guerre-Millo, M., Berthault, M.-F., Dugail, I., Morin, J., Auwerx, J., & Ferré, P. (1997) · Diabetes · doi:10.2337/diab.46.9.1393 · Cited by 306
Transcriptional control of adipogenesis
Fajas, L., Fruchart, J.-C., & Auwerx, J. (1998) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(98)80138-5 · Cited by 303
Vu-Dac, N., Chopin-Delannoy, S., Gervois, P., Bonnelye, E., Martin, G., Fruchart, J.-C., Laudet, V., & Staels, B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.25713 · Cited by 297
Beamer, B. A., Yen, C. J., Andersen, R. E., Muller, D., Elahi, D., Cheskin, L. J., Andres, R., Roth, J., & Shuldiner, A. R. (1998) · Diabetes · doi:10.2337/diabetes.47.11.1806 · Cited by 293
Wahli, W., Braissant, O., & Desvergne, B. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90045-4 · Cited by 291
Rebrin, K., Steil, G. M., Mittelman, S. D., & Bergman, R. N. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118846 · Cited by 289
DiRenzo, J., Söderström, M., Kurokawa, R., Ogliastro, M.-H., Ricote, M., Ingrey, S., Hörlein, A., Rosenfeld, M. G., & Glass, C. K. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.4.2166 · Cited by 284
Werman, A., Hollenberg, A., Solanes, G., Bjørbæk, C., Vidal-Puig, A. J., & Flier, J. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.20230 · Cited by 282
Hepatic peroxisome proliferation in rodents and its significance for humans
Bentley, P., Calder, I., Elcombe, C., Grasso, P., Stringer, D., & Wiegand, H.-J. (1993) · Food and Chemical Toxicology · doi:10.1016/0278-6915(93)90225-n · Cited by 271
Mukherjee, R., Jow, L., Noonan, D., & McDonnell, D. P. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90089-2 · Cited by 270
Sears, I. B., MacGinnitie, M. A., Kovacs, L. G., & Graves, R. A. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3410 · Cited by 270
Free Fatty Acid as a Link in the Regulation of Hepatic Glucose Output by Peripheral Insulin
Rebrin, K., Steil, G. M., Getty, L., & Bergman, R. N. (1995) · Diabetes · doi:10.2337/diab.44.9.1038 · Cited by 270
Crystal Structure of the Ligand Binding Domain of the Human Nuclear Receptor PPARγ
Uppenberg, J., Svensson, C., Jaki, M., Bertilsson, G., Jendeberg, L., & Berkenstam, A. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.47.31108 · Cited by 260
Murakami, K., Tobe, K., Ide, T., Mochizuki, T., Ohashi, M., Akanuma, Y., Yazaki, Y., & Kadowaki, T. (1998) · Diabetes · doi:10.2337/diabetes.47.12.1841 · Cited by 255
Evolutionary aspects of omega-3 fatty acids in the food supply
Simopoulos, A. P. (1999) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(99)80023-4 · Cited by 252
Dietary Fat and Prostate Cancer: Current Status
Kolonel, L. N., Nomura, A. M. Y., & Cooney, R. V. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.5.414 · Cited by 251
Berthou, L., Duverger, N., Emmanuel, F., Langouët, S., Auwerx, J., Guillouzo, A., Fruchart, J. C., Rubin, E., Denèfle, P., Staels, B., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118687 · Cited by 248
Do Peroxisome Proliferating Compounds Pose a Hepatocarcinogenic Hazard to Humans?
Cattley, R. C., DeLuca, J., Elcombe, C., Fenner-Crisp, P., Lake, B. G., Marsman, D. S., Pastoor, T. A., Popp, J. A., Robinson, D. E., Schwetz, B., et al. (1998) · Regulatory Toxicology and Pharmacology · doi:10.1006/rtph.1997.1163 · Cited by 244
Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat
Hallakou, S., Doaré, L., Foufelle, F., et al. (1997) · Diabetes · doi:10.2337/diabetes.46.9.1393 · Cited by 243
Regulation of the peroxisome proliferator-activated receptor alpha gene by glucocorticoids.
Lemberger, T., Staels, B., Saladin, R., Desvergne, B., Auwerx, J., & Wahli, W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31420-5 · Cited by 233
Torra, I. P., Gervois, P., & Staels, B. (1999) · Current Opinion in Lipidology · doi:10.1097/00041433-199904000-00009 · Cited by 231
A Regulatory Role for RIP140 in Nuclear Receptor Activation
Treuter, E. (1998) · Molecular Endocrinology · doi:10.1210/me.12.6.864 · Cited by 230
Meirhaeghe, A. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.3.435 · Cited by 207
Lambe, K. G., & Tugwood, J. D. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0001u.x · Cited by 198
NEEDLE PUNCTURE OF THE FETUS DURING AMNIOCENTESIS
Broome, D., Kellogg, B., Weiss, B., & Wilson, M. (1975) · The Lancet · doi:10.1016/s0140-6736(75)90191-9 · Cited by 198
Peroxisome proliferator-activated receptor agonists
Willson, T. M., & Wahli, W. (1997) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(97)80015-4 · Cited by 198
Self-citationRibon, V., Johnson, J. H., Camp, H. S., & Saltiel, A. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14751 · Cited by 196
Biological activities and mechanisms of action of PGJ2 and related compounds: an update
Fukushima, M. (1992) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(92)90178-l · Cited by 186
Walker, A. B., Chattington, P. D., Buckingham, R. E., & Williams, G. (1999) · Diabetes · doi:10.2337/diabetes.48.7.1448 · Cited by 185
Satoh, H., Tsukamoto, K., Hashimoto, Y., Hashimoto, N., Togo, M., Hara, M., Maekawa, H., Isoo, N., Kimura, S., & Watanabe, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.0126 · Cited by 182
Brown, K. K., Henke, B. R., Blanchard, S. G., Cobb, J. E., Mook, R., Kaldor, I., Kliewer, S. A., Lehmann, J. M., Lenhard, J. M., Harrington, W. W., et al. (1999) · Diabetes · doi:10.2337/diabetes.48.7.1415 · Cited by 172
Self-citationZhou, G. (1998) · Molecular Endocrinology · doi:10.1210/me.12.10.1594 · Cited by 172
The nuclear factor‐κB/inhibitor of kappa B autoregulatory system and atherosclerosis
Thurberg, B. L., & Collins, T. (1998) · Current Opinion in Lipidology · doi:10.1097/00041433-199810000-00002 · Cited by 166
Souza, S. C., Yamamoto, M. T., Franciosa, M. D., Lien, P., & Greenberg, A. S. (1998) · Diabetes · doi:10.2337/diabetes.47.4.691 · Cited by 166
A role for fatty acids and liver fatty acid binding protein in peroxisome proliferation?
Issemann, I., Prince, R., Tugwood, J., & Green, S. (1992) · Biochemical Society Transactions · doi:10.1042/bst0200824 · Cited by 164
Swing of the lever arm of a myosin motor at the isomerization and phosphate-release steps
Suzuki, Y., Yasunaga, T., Ohkura, R., Wakabayashi, T., & Sutoh, K. (1998) · Nature · doi:10.1038/24640 · Cited by 160
Bastie, C. C., Holst, D., Gaillard, D., Jehl-Piétri, C., & Grimaldi, P. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21920 · Cited by 160
Kato, K., Satoh, H., Endo, Y., Yamada, D., Midorikawa, S., Sato, W., Mizuno, K., Fujita, T., Tsukamoto, K., & Watanabe, T. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0648 · Cited by 160
Up-Regulation of UCP-2 Gene Expression by PPAR Agonists in Preadipose and Adipose Cells
Aubert, J., Champigny, O., Saint-Marc, P., Negrel, R., Collins, S., Ricquier, D., & Ailhaud, G. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7348 · Cited by 159
Chen, F., Law, S. W. T., & O’Malley, B. W. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2302 · Cited by 156
Brun, S., Carmona, M. C., Mampel, T., Viñas, O., Giralt, M., Iglesias, R., & Villarroya, F. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1217 · Cited by 156
Antihypertensive effects of CS-045 treatment in obese Zucker rats
Yoshioka, S., Nishino, H., Shiraki, T., Ikeda, K., Koike, H., Okuno, A., Wada, M., Fujiwara, T., & Horikoshi, H. (1993) · Metabolism · doi:10.1016/0026-0495(93)90175-n · Cited by 153
Pro12Ala Missense Mutation of the Peroxisome Proliferator Activated Receptor γ and Diabetes Mellitus
Ringel, J., Engeli, S., Distler, A., & Sharma, A. M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9962 · Cited by 152
An eclipsing millisecond pulsar in the globular cluster Terzan 5
Lyne, A. G., Manchester, R. N., D’Amico, N., Staveley‐Smith, L., Johnston, S., Lim, J., Fruchter, A. S., Goss, W. M., & Frail, D. A. (1990) · Nature · doi:10.1038/347650a0 · Cited by 150
Young, P. W., Cawthorne, M. A., Coyle, P. J., Holder, J. C., Holman, G. D., Kozka, I. J., Kirkham, D. M., Lister, C. A., & Smith, S. A. (1995) · Diabetes · doi:10.2337/diab.44.9.1087 · Cited by 146
Roberts, R. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.43 · Cited by 140
PPARγ activators improve glucose homeostasis by stimulating fatty acid uptake in the adipocytes
Martin, G., Schoonjans, K., Staels, B., & Auwerx, J. H. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00315-8 · Cited by 138
Kemnitz, J. W., Elson, D. F., Roecker, E. B., Baum, S. T., Bergman, R. N., & Meglasson, M. D. (1994) · Diabetes · doi:10.2337/diab.43.2.204 · Cited by 137
PPARγ in Monocytes: Less Pain, Any Gain?
Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81567-6 · Cited by 135
Heinlein, C. A., Ting, H., Yeh, S., & Chang, C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16147 · Cited by 135
Digby, J. E., Montague, C. T., Sewter, C. P., Sanders, L., Wilkison, W. O., O'Rahilly, S., & Prins, J. B. (1998) · Diabetes · doi:10.2337/diab.47.1.138 · Cited by 134
Regulation of apo A-I gene expression by fibrates
Staels, B., & Auwerx, J. H. (1998) · Atherosclerosis · doi:10.1016/s0021-9150(97)00313-4 · Cited by 124
Fonseca, V. A., Reynolds, T., Hemphill, D., Randolph, C., Wall, J., Valiquett, T. R., Graveline, J. F., & Fink, L. M. (1998) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(97)00109-8 · Cited by 123
An adipogenic cofactor bound by the differentiation domain of PPARγ
Castillo, G., Brun, R. P., Rosenfield, J. K., Hauser, S., Park, C. W., Troy, A. E., Wright, M. E., & Spiegelman, B. M. (1999) · The EMBO Journal · doi:10.1093/emboj/18.13.3676 · Cited by 119
Emerging Therapies for the Prevention or Treatment of Postmenopausal Osteoporosis
Sato, M., Grese, T. A., Dodge, J. A., Bryant, H. U., & Turner, C. H. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980344o · Cited by 116
Koch, M., Kristian, R. E. T. T., Maerker, E., Volk, A., Haist, K., Deninger, M., Renn, W., & Häring, H. (1999) · Diabetologia · doi:10.1007/s001250051225 · Cited by 114
Sfeir, Z., Ibrahimi, A., Amri, E., Grimaldi, P. A., & Abumrad, N. A. (1997) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(97)90487-7 · Cited by 112
Nichols, J. S., Parks, D. J., Consler, T. G., & Blanchard, S. G. (1998) · Analytical Biochemistry · doi:10.1006/abio.1997.2557 · Cited by 109
Identification of peroxisome proliferator-activated receptor ligands from a biased chemical library
Brown, P. J., Smith-Oliver, T. A., Charifson, P. S., Tomkinson, N. C. O., Fivush, A. M., Sternbach, D. D., Wade, L., Orband‐Miller, L. A., Parks, D. J., Blanchard, S. G., et al. (1997) · Chemistry & Biology · doi:10.1016/s1074-5521(97)90299-4 · Cited by 109
Self-citationCamirand, A., Marie, V., Rabelo, R., & Silva, J. E. (1998) · Endocrinology · doi:10.1210/endo.139.1.5808 · Cited by 109
(3-Substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agents
Nomura, M., Kinoshita, S., Satoh, H., Maeda, T., Murakami, K., Tsunoda, M., Miyachi, H., & Awano, K. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00039-6 · Cited by 105
L-764406 Is a Partial Agonist of Human Peroxisome Proliferator-activated Receptor γ
Elbrecht, A., Chen, Y., Adams, A., Berger, J. P., Griffin, P. R., Klatt, T., Zhang, B., Menke, J. G., Zhou, G., Smith, R. G., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7913 · Cited by 105
Cloning and Characterization of the 5′ Flanking Region of the Human Uncoupling Protein 3 (UCP3) Gene
Acı́n, A., Rodriguez, M., Rique, H., Canet, E., Boutin, J. A., & Galizzi, J. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0530 · Cited by 103
Influence of fenofibrate on cellular and subcellular liver structure in hyperlipidemic patients
Blümcke, S., Schwartzkopff, W., Lobeck, H., Edmondson, N. A., Prentice, D. A., & Blane, G. F. (1983) · Atherosclerosis · doi:10.1016/0021-9150(83)90169-7 · Cited by 102
RXR Agonists Activate PPARα-Inducible Genes, Lower Triglycerides, and Raise HDL Levels In Vivo
Mukherjee, R., Strasser, J., Jow, L., Hoener, P. A., Paterniti, J. R., & Heyman, R. A. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.2.272 · Cited by 100
Recent update on the PPARα-null mouse
Gonzalez, F. J. (1997) · Biochimie · doi:10.1016/s0300-9084(97)81506-4 · Cited by 95
Malmendier, C. L., Lontie, J., Delcroix, C., Dubois, D. Y., Magot, T., & Roy, L. D. (1989) · Atherosclerosis · doi:10.1016/0021-9150(89)90075-0 · Cited by 94
Effects of ciglitazone on blood pressure and intracellular calcium metabolism.
Pershadsingh, H. A., Szöllõsi, J., Benson, S., Hyun, W. C., Feuerstein, B. G., & Kurtz, T. W. (1993) · Hypertension · doi:10.1161/01.hyp.21.6.1020 · Cited by 92
Ericsson, C.-G., Nilsson, J. Å., Grip, L., Svane, B., & Hamsten, A. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00626-7 · Cited by 91
Jones, I. R., Swai, A. B. M., Taylor, R., Miller, M. A., Laker, M. F., & Alberti, K. G. M. M. (1990) · Diabetes Care · doi:10.2337/diacare.13.8.855 · Cited by 90
Johnson, T. E., Holloway, M. K., Vogel, R., Rutledge, S. J., Perkins, J. J., Rodan, G. A., & Schmidt, A. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00064-2 · Cited by 88
Beamer, B. A., Negri, C., Yen, C., Gavrilova, O., Rumberger, J. M., Durcan, M. J., Yarnall, D. P., Hawkins, A. L., Griffin, C. A., Burns, D. K., et al. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6540 · Cited by 87
Prediction of the structure of a receptor–protein complex using a binary docking method
Stoddard, B. L., & Koshland, D. E. (1992) · Nature · doi:10.1038/358774a0 · Cited by 85
Yoshimoto, T., Naruse, M., Shizume, H., Naruse, K., Tanabe, A., Tanaka, M., Tago, K., Irie, K., Muraki, T., Demura, H., et al. (1999) · Atherosclerosis · doi:10.1016/s0021-9150(99)00085-4 · Cited by 85
The peroxisome proliferator-activated receptors at the cross-road of diet and hormonal signalling
Desvergne, B., Ijpenberg, A., Devchand, P. R., & Wahli, W. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(97)00182-9 · Cited by 83
Kruszynska, Y. T., Mukherjee, R., Jow, L., Dana, S. L., Paterniti, J. R., & Olefsky, J. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1076 · Cited by 82
Aperlo, C., Pognonec, P., Saladin, R., Auwerx, J. H., & Boulukos, K. E. (1995) · Gene · doi:10.1016/0378-1119(95)00196-d · Cited by 80
Auwerx, J. H. (2008) · Hormone Research · doi:10.1159/000182557 · Cited by 77
Banner, C. D., Göttlicher, M., Widmark, E., Sjövall, J., Jj, R., & Gustafsson, J. (1993) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)36951-0 · Cited by 76
Improvement of Glucose Tolerance in NIDDM by Clofibrate Randomized Double-Blind Study
Kobayashi, M., Shigeta, Y., Hirata, Y., Omori, Y., Sakamoto, N., NAMBU, S., & Baba, S. (1988) · Diabetes Care · doi:10.2337/diacare.11.6.495 · Cited by 75
Miyata, K., McCaw, S. E., Meertens, L. M., Patel, H. V., Rachubinski, R. A., & Capone, J. P. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00196-8 · Cited by 74
Monogenic disorders of obesity and body fat distribution
Chen, D., & Garg, A. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34890-2 · Cited by 69
Graf, K., Xi, X.-P., Hsueh, W. A., & Law, R. E. (1997) · FEBS Letters · doi:10.1016/s0014-5793(96)01371-3 · Cited by 68
The significance of polyunsaturated fatty acids in cutaneous biology
Ziboh, V. A. (1996) · Lipids · doi:10.1007/bf02637085 · Cited by 67
Mechanisms and clinical effects of thiazolidinediones
Grossman, S. L., & Lessem, J. N. (1997) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.6.8.1025 · Cited by 66
The optimal ratio of fat-to-carbohydrate in the diet.
Grundy, S. (1999) · Annual review of nutrition · doi:10.1146/annurev.nutr.19.1.325 · Cited by 65
HYPERTENSION AND INSULIN RESISTANCE: ROLE OF PEROXISOME PROLIFERATOR‐ACTIVATED RECEPTOR γ
Itoh, H., Doi, K., Tanaka, T., Fukunaga, Y., Hosoda, K., Inoue, G., Nishimura, H., Yoshimasa, Y., Yamori, Y., & Nakao, K. (1999) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.1999.03082.x · Cited by 63
Effects of -chlorophenoxyisobutyric acid (CPIB) on the human liver
Hanefeld, M., Kemmer, C., Leonhardt, W., Kunze, K. D., Jaroß, W., & HALLER, H. (1980) · Atherosclerosis · doi:10.1016/0021-9150(80)90225-7 · Cited by 62
Lambe, K. G., Woodyatt, N. J., Macdonald, N., Chevalier, S., & Roberts, R. A. (1999) · Toxicology Letters · doi:10.1016/s0378-4274(99)00151-4 · Cited by 60
Novel Euglycemic and Hypolipidemic Agents. 4. Pyridyl- and Quinolinyl-Containing Thiazolidinediones
Lohray, B. B., Bhushan, V., Reddy, A. S., Rao, P. B., Reddy, N. J., Harikishore, P., Haritha, N., Vikramadityan, R. K., Chakrabarti, R., Rajagopalan, R., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980622j · Cited by 59
Upton, R., Widdowson, P. S., Ishii, S., Tanaka, H., & Williams, G. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702245 · Cited by 58
Differential activity of rosiglitazone enantiomers at PPARγ
Parks, D. J., Tomkinson, N. C. O., Villeneuve, M. S., Blanchard, S. G., & Willson, T. M. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00664-7 · Cited by 57
Self-citationMetabolic effects of darglitazone, an insulin sensitizer, in NIDDM subjects
Chaiken, R. L., Eckert‐Norton, M., Pasmantier, R., Boden, G., Ryan, I., Gelfand, R. A., & Lebovitz, H. E. (1995) · Diabetologia · doi:10.1007/bf00401763 · Cited by 54
Requirements for Triggering of Adipocyte Differentiation by Glucocorticoids and Indomethacin*
Knight, D. M., Chapman, A. B., Navre, M., Drinkwater, L., Bruno, J. J., & RINGOLD, G. M. (1987) · Molecular Endocrinology · doi:10.1210/mend-1-1-36 · Cited by 54
Wang, Q., Dryden, S. D., Frankish, H. M., Bing, C., Pickavance, L. C., Hopkins, D., Buckingham, R. E., & Williams, G. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701535 · Cited by 53
Knock, G. A., Mishra, S. K., & Aaronson, P. I. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00020-5 · Cited by 53
Shibata, T., Matsui, K., Nagao, K., Shinkai, H., Yonemori, F., & Wakitani, K. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00832-2 · Cited by 52
Gimble, J. M., Pighetti, G. M., Lerner, M. R., Wu, X., Lightfoot, S. A., Brackett, D. J., Darcy, K. M., & Hollingsworth, A. B. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9858 · Cited by 52
Expression and cDNA cloning of porcine peroxisome proliferator-activated receptor gamma (PPARγ)
Houseknecht, K. L., Bidwell, C. A., Portocarrero, C. P., & Spurlock, M. E. (1998) · Gene · doi:10.1016/s0378-1119(98)00533-2 · Cited by 52
Satoh, T., Furuta, K., Suzuki, M., & Watanabe, Y. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0587 · Cited by 51
Shepherd, J. (1994) · Drugs · doi:10.2165/00003495-199400472-00003 · Cited by 49
Schmidt, A., Vogel, R. L., Witherup, K. M., Rutledge, S. J., Pitzenberger, S. M., Adam, M., & Rodan, G. A. (1996) · Lipids · doi:10.1007/bf02524285 · Cited by 44
Pickavance, L. C., Widdowson, P. S., King, P. A., Ishii, S., Tanaka, H., & Williams, G. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702158 · Cited by 43
Cabrero, À., Llaverías, G., Roglans, N., Alegret, M., Sánchez, R. M., Adzet, T., Laguna, J. C., & Vázquez‐Carrera, M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0926 · Cited by 41
Saku, K. (1997) · American Journal of Hypertension · doi:10.1016/s0895-7061(97)00160-x · Cited by 40
Jüngling, E., & Kammermeier, H. (1988) · Analytical Biochemistry · doi:10.1016/0003-2697(88)90136-4 · Cited by 39
Attenuation of Hypertension by Insulin-Sensitizing Agents
Kotchen, T. A. (1996) · Hypertension · doi:10.1161/01.hyp.28.2.219 · Cited by 38
Alegret, M., Ferrando-Miguel, R., Vázquez‐Carrera, M., Adzet, T., Merlos, M., & Laguna, J. C. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb13109.x · Cited by 37
Vázquez‐Carrera, M., Merlos, M., Adzet, T., & Laguna, J. C. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16710.x · Cited by 35
Research works printed but not linked: 124
- Lichtenstein A. H., 1998, Nutr. Rev., 56, S28
- Harris M. I., 1998, Diabetes Care, 21, 524
- Howard B. V., 1995, Int. Congr. Ser.
- Barzilai N., 1999, J. Gerontol., Ser. A, 54, B96
- Lichtenstein A. H., 1999, Nutr. Rev., 57, 14
- Jump D. B., 1999, Annu. Rev. Nutr., 19, 90
- Mangelsdorf D. J., 1995, Cell, 83, 850
- A, 1999, Cell, 97, 163
- Xu H. E., 1999, Mol. Cell, 3, 403
- Hu E., 1996, Science, 274, 2103
- Zhang B., 1996, J. Biol. Chem., 271, 31774
- Adams M., 1997, J. Biol. Chem., 272, 5132
- Camp H. S., 1999, Endocrinology, 140, 397
- Juge-Aubry C. E., 1999, J. Biol. Chem., 274, 10510
- McDonnell D. P., 1993, Bio/Technology, 11, 1261
- Lehmann J. M., 1995, J. Biol. Chem., 270, 12956
- Xu L., 1999, Curr. Opin. Genet. Dev., 9, 147
- Zhu Y., 1996, Gene Expression, 6, 195
- Dowell P., 1997, J. Biol. Chem., 272, 33443
- Zhu Y., 1997, J. Biol. Chem., 272, 25506
- Yuan C.-X., 1998, Proc. Natl. Acad. Sci. U.S.A., 95, 7944
- Treuter E., 1998, Mol. Endocrinol., 12, 881, 10.1210/mend.12.6.0123 · doi:10.1210/mend.12.6.0123 · Paper page
- Krey G., 1997, Mol. Endocrinol., 11, 791, 10.1210/mend.11.6.0007 · DOI · Paper page
- Zhou G., 1998, Mol. Endocrinol., 12, 1604, 10.1210/mend.12.10.0176 · doi:10.1210/mend.12.10.0176 · Paper page
- Berger J., 1996, Endocrinology, 137, 4195
- Young P. W., 1998, J. Pharmacol. Exp. Ther., 284, 759
- Bell A. R., 1998, Biochem. J., 332, 693
- Heuvel J. P. V, 1999, Toxicol. Sci., 47, 8
- Palmer C. N. A., 1998, Mol. Pharmacol., 53, 22
- Gervois P., 1999, Mol. Endocrinol., 13, 1549
- Gaw A., 1994, Handb. Exp. Pharmacol., 109, 348
- Brown P. J., 1997, Synthesis, 778, 782
- Brown P. J., 1999, J. Med. Chem., 42, 3788
- Forman B. M., 1997, Proc. Natl. Acad. Sci. U.S.A., 94, 4317
- Yu K., 1995, J. Biol. Chem., 270, 23983
- Palmer C. N. A., 1994, J. Biol. Chem., 269, 18089
- Lee S. S.-T., 1995, Mol. Cell. Biol., 15, 3022
- Peters J. M., 1997, J. Biol. Chem., 272, 27312
- Gaw A., 1999, Lipoproteins Health Dis., 1145, 1160
- Ross S. D., 1999, Arch. Intern. Med., 159, 1802
- Oliver M. F., 1984, Lancet, 2, 604
- Rutolo G., 1998, J. Am. Coll. Cardiol., 32, 1656
- Libby P., 1999, Mol. Basis Cardiovasc. Dis., 349, 366
- Spencer N. F. L., 1997, Int. Immunol., 9, 1588
- Delerive P., 1999, J. Biol. Chem., 45, 32054
- Vazquez M., 1995, Br. J. Pharmacol., 116, 2075
- Jacobsson A., 1985, J. Biol. Chem., 260, 16254
- Krook A., 1998, Diabetes, 47, 1531
- Ruyter B., 1997, Biochim. Biophys. Acta, 1348, 338
- Zhu Y., 1993, J. Biol. Chem., 268, 26820
- Greene M. E., 1995, Gene Expression, 4, 299
- Chawla A., 1994, Endocrinology, 135, 800, 10.1210/endo.135.2.8033830 · doi:10.1210/endo.135.2.8033830 · Paper page
- Saladin R., 1999, Cell Growth Differ., 10, 48
- Martin G., 1997, J. Biol. Chem., 272, 28217
- Hofmann C., 1994, Endocrinology, 134, 270, 10.1210/endo.134.1.8275942 · DOI · Paper page
- Tai T.-A. C., 1996, J. Biol. Chem., 271, 29914
- Kelly L. J., 1998, Endocrinology, 139, 4927
- Hulin B., 1996, Curr. Pharm. Des., 2, 102
- Kletzien R. F., 1992, Mol. Pharmacol., 41, 398
- Ibrahimi A., 1994, Mol. Pharmacol., 46, 1076
- Harris P. K. W., 1994, Mol. Pharmacol., 45, 445
- Willson T. M., 1996, J. Med. Chem., 39, 668
- Ide T., 1998, Diabetes Front, 9, 346
- Shinkai H., 1998, J. Med. Chem., 41, 1933
- Reginato M. J., 1998, J. Biol. Chem., 273, 32684
- Reddy K. A., 1999, J. Med. Chem., 42, 3278
- Sohda T., 1984, Chem. Pharm. Bull., 32, 4465
- Buckle D. R., 1996, Bioorg. Med. Chem. Lett., 6, 2126
- Buckle D. R., 1996, Bioorg. Med. Chem. Lett., 6, 2130
- Henke B. R., 1998, Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents. J. Med. Chem
- Collins J. L., 1998, Structure−activity relationship and optimization of the phenyl alkyl ether moiety. J. Med. Chem
- Cobb J. E., 1998, N-(2-Benzoylphenyl)-l-tyrosine PPARγ agonists. 3. Structure−activity relationship and optimization of the N-aryl substituent. J. Med. Chem., 41, 5069
- Lehmann J. M., 1997, J. Biol. Chem., 272, 3410
- Verrando P., 1981, Biochim. Biophys. Acta, 663, 265
- Negishi M., 1995, J. Lipid Mediators Cell Signalling, 12, 448
- Narumiya S., 1991, Dev. Oncol., 67, 448
- Ikeda H., 1990, Arzneim.-Forsch., 40, 162
- Horikoshi H., 1994, Annu. Rep. Sankyo Res. Lab., 46, 57
- Prigeon R. L., 1998, J. Clin. Endocrinol. Metab., 83, 823
- Fonseca V. A., 1998, J. Clin. Endocrinol. Metab., 83, 3176
- Spencer C. M., 1997, Drugs, 54, 101
- Kumar S., 1996, Diabetologia, 39, 709
- Gimble J. M., 1996, Mol. Pharmacol., 50, 1094
- Jones S. A., 2000, Mol. Endocrinol., 14, 39, 10.1210/mend.14.1.0409 · doi:10.1210/mend.14.1.0409 · Paper page
- Blumberg B., 1998, Genes Dev., 12, 3205
- Ramachandran V., 1999, Drug Metab. Dispos., 27, 1199
- Yamazaki H., 1999, Drug Metab. Dispos., 27, 1266
- Pumford N. R., 1997, Annu. Rev. Pharmacol. Toxicol., 37, 117
- Miller V. A., 1997, J. Clin. Oncol., 15, 795
- Rizvi N. A., 1999, Clin. Cancer Res., 5, 1664
- Vidal-Puig A. J., 1997, J. Clin. Invest., 99, 2422
- Park K. S., 1997, Diabetes, 46, 1234
- Wu Z., 1998, J. Clin. Invest., 101, 32
- Sreenan S., 1999, Am. J. Physiol., 276, E1129
- Miles P. D. G., 1997, Diabetes, 46, 1683
- Yen C.-J., 1997, Biochem. Biophys. Res. Commun., 241, 274
- Deeb S. S., 1998, Nat. Genet., 20, 287
- Valve R., 1999, J. Clin. Endocrinol. Metab., 84, 3712
- Mori Y., 1998, Biochem. Biophys. Res. Commun., 251, 198
- Ek J., 1999, Diabetologia, 42, 895
- Hamann A., 1999, Eur. J. Endocrinol., 141, 92
- Girard J, 1997, Diabetes Metab., 23, 24
- McKeigue P., 1997, Handb. Hypertens., 17, 934
- Dubey R. K., 1993, Am. J. Physiol., 265, R732
- Zhang H. Y., 1994, Hypertension, 24, 110
- Morikang E., 1997, Am. J. Hypertens., 10, 446
- Law R. E., 1996, J. Clin. Invest., 98, 1905
- Kotchen T. A., 1996, Am. J. Physiol., 270, R666
- Zhang F., 1994, Hypertension, 24, 175
- Su C. G., 1999, J. Clin. Invest., 104, 389
- Ehrmann D. A., 1997, J. Clin. Endocrinol. Metab., 82, 2116
- Minamikawa J., 1998, J. Clin. Endocrinol. Metab., 83, 1820
- Suh N., 1999, Cancer Res., 59, 5673
- Lefebvre A.-M., 1998, Nat. Med., 4, 1057
- Schmidt A., 1992, Mol. Endocrinol., 6, 1641
- Amri E.-Z., 1995, J. Biol. Chem., 270, 2371
- Brooks C. D. W., 1996, J. Med. Chem., 39, 2654
- Brun R. P., 1996, Genes Dev., 10, 984
- Lim H., 1999, Genes Dev., 13, 1574
- He T.-C., 1999, Cell, 99, 345
- Cobb J., 1998, Annu. Rep. Med. Chem., 33, 222
- Sliskovic D. R., 1999, Annu. Rep. Med. Chem., 34, 110
- Belch J. J. F., 1998, Proc. Nutr. Soc., 57, 569
- Woutersen R. A., 1999, Mutat. Res., 443, 127
Cited by
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
“However, it is probable that PPARγ is the biological target of the anti-diabetic actions of TZDs: there is a strong correlation between PPARγ binding in vitro and glucose lowering in vivo”
BackgroundThe mechanisms of action of PPARs
Berger, J., & Moller, D. E. (2002) · Annual Review of Medicine · doi:10.1146/annurev.med.53.082901.104018 · Cited by 2,659
Nuclear Receptors and Lipid Physiology: Opening the X-Files
Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085
Pawlak, M., Lefebvre, P., & Staels, B. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.039 · Cited by 1,578
“Moreover, despite numerous reports of beneficial effects of fibrates in mice, species-specific differences may exist in the response to PPARa agonism [32].”
BackgroundBouhlel, M. A., Derudas, B., Rigamonti, E., Dièvart, R., Brozek, J., Haulon, S., Zawadzki, C., Jude, B., Torpier, G., Marx, N., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.06.010 · Cited by 1,325
Metadata
- Authors
- Willson, T. M., Brown, P. J., Sternbach, D. D., & Henke, B. R.
- Affiliations
- Department of Medicinal Chemistry, Glaxo Wellcome Research & Development, Research Triangle Park, North Carolina 27709
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2000-02-01
- Volume
- 43
- Issue
- 4
- Pages
- 527-550
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W1977666051
- Cited by
- 1,816
- References
- 216
- Citations by year
- 2026: 18 · 2025: 28 · 2024: 27 · 2023: 35 · 2022: 38 · 2021: 41 · 2020: 38 · 2019: 44 · 2018: 46 · 2017: 44 · 2016: 37 · 2015: 60 · 2014: 62 · 2013: 52 · 2012: 92
- FWCI
- 7.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- peroxisome proliferator-activated receptors, orphan receptors, drug discovery, receptor agonists, ligands, lipid signaling, nuclear receptors
- MeSH terms
- Animals, Diabetes Mellitus, Humans, Hyperlipidemias, Hypertension, Inflammation, Ligands, Models, Molecular, Neoplasms, Nuclear Proteins, Obesity, Transcription Factors, Drug Design, Receptors, Cytoplasmic and Nuclear
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.